- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Myeloma
Total 7109 results
-
Dana-Farber Cancer InstituteBeth Israel Deaconess Medical Center; Brigham and Women's Hospital; H. Lee Moffitt...CompletedMultiple Myeloma | Refractory Multiple Myeloma | Relapsed Multiple MyelomaUnited States
-
Johnson & Johnson Pharmaceutical Research & Development...Tibotec Therapeutics, a Division of Ortho Biotech Products, L.P., USACompletedMultiple Myeloma | Myeloma | M-Protein | Myeloma Proteins
-
University of Erlangen-Nürnberg Medical SchoolGerman Research Foundation; University Hospital, Essen; Wuerzburg University... and other collaboratorsUnknownAcute Myeloid Leukemia | Multiple Myeloma | Acute Lymphoblastic Leukemia | Chronic Myeloid Leukemia | Myelodysplastic Syndrome | Aplastic Anemia | Non Hodgkin's Lymphoma | Hodgkin's DiseaseGermany
-
Oxford University Hospitals NHS TrustAmgenCompletedMyeloma | Smouldering Myeloma | Monoclonal Gammopathy of Undetermined Significance (MGUS)United Kingdom
-
SanofiNot yet recruiting
-
Thomas Martin, MDBristol-Myers Squibb; Janssen Research & Development, LLCNot yet recruitingMultiple Myeloma | Refractory Multiple Myeloma | Relapsed Multiple MyelomaUnited States
-
Cartesian TherapeuticsRecruitingRefractory Multiple Myeloma | Relapsed Multiple MyelomaUnited States
-
PETHEMA FoundationRecruitingMultiple Myeloma in RelapseSpain
-
Janssen Research & Development, LLCRecruitingRelapsed or Refractory Multiple MyelomaKorea, Republic of, Italy, Germany, France, Japan, Israel, Belgium, Denmark, Sweden, Canada, Spain, Czechia, Poland, Australia, Netherlands, United Kingdom, India, China
-
Medical College of WisconsinRecruitingRefractory Multiple Myeloma | Relapse Multiple MyelomaUnited States
-
Thomas Martin, MDUniversity of California, Davis; Actavis Inc.; Eugia Pharma Specialities LimitedActive, not recruitingRefractory Multiple Myeloma | Relapsed Multiple MyelomaUnited States
-
Andrew Yee, MDBristol-Myers Squibb; Takeda Pharmaceuticals North America, Inc.TerminatedRefractory Multiple Myeloma | Relapsed Multiple MyelomaUnited States
-
Wuerzburg University HospitalClinAssess GmbH; Arbeitsgemeinschaft medikamentoese TumortherapieActive, not recruitingNewly Diagnosed Multiple MyelomaGermany, Austria
-
University of ChicagoNational Cancer Institute (NCI); Multiple Myeloma Research FoundationActive, not recruitingPlasma Cell Myeloma | Residual DiseaseUnited States
-
Thomas Martin, MDWithdrawnRefractory Multiple Myeloma | Relapsed Multiple Myeloma
-
Genentech, Inc.CompletedRefractory Multiple Myeloma | Relapsed Multiple MyelomaBelgium, Australia, Denmark, Norway
-
Tulane University School of MedicineKaryopharm Therapeutics IncWithdrawnRefractory Multiple Myeloma | Relapsed Multiple Myeloma
-
University of Colorado, DenverTerminatedRefractory Plasma Cell MyelomaUnited States
-
AbbVieActive, not recruitingAcute Myeloid Leukemia | Cancer | Multiple Myeloma | Non-Hodgkin's Lymphoma | Acute Lymphoblastic Leukemia | Chronic Lymphocytic LeukemiaUnited States, Australia, Belgium, Canada, Denmark, France, Greece, Hong Kong, Ireland, Japan, Korea, Republic of, Mexico, New Zealand, Poland, Portugal, Russian Federation, Spain, Sweden, Taiwan, Turkey, Ukraine, United Kingdom, Au...
-
Medigene AGWithdrawnAcute Myeloid Leukemia | Myelodysplastic Syndromes | Myeloproliferative Disorders | Multiple Myeloma | Myelofibrosis | Chronic Myeloid Leukemia | Acute Lymphoid Leukemia | Malignant LymphomaNetherlands
-
Singapore General HospitalNational Medical Research Council (NMRC), SingaporeCompletedAcute Myeloid Leukemia | Multiple Myeloma | Acute Lymphoblastic Leukemia | Chronic Myeloid Leukemia | Myelodysplastic Syndrome | Non Hodgkin's Lymphoma | Hodgkin's DiseaseSingapore
-
Jonsson Comprehensive Cancer CenterNovartis PharmaceuticalsWithdrawnRefractory Plasma Cell Myeloma | Recurrent Plasma Cell Myeloma | HLA-A*0201 Positive Cells Present | NY-ESO-1 Positive Tumor Cells PresentUnited States
-
Jennifer Eva SelfridgeSuspendedAcute Myeloid Leukemia | Myelodysplastic Syndromes | Colorectal Cancer | Hodgkin Lymphoma | Acute Lymphoblastic Leukemia | Chronic Lymphocytic Leukemia | Non Hodgkin Lymphoma | Chronic Myeloid Leukemia | Plasma Cell Myeloma | Hematologic Malignancy | Rectum Cancer | Myeloproliferative SyndromeUnited States
-
The First Affiliated Hospital of Xiamen UniversityRecruitingMultiple Myeloma in Relapse | Multiple Myeloma, RefractoryChina
-
OncotherapeuticsNot yet recruitingMultiple Myeloma in Relapse | Multiple Myeloma, Refractory
-
Dong-A University HospitalNot yet recruitingMultiple Myeloma in Relapse | Multiple Myeloma, Refractory
-
Amsterdam UMC, location VUmcNot yet recruitingMultiple Myeloma | Multiple Myeloma in Relapse | Multiple Myeloma, Refractory
-
Luminary TherapeuticsThe Cleveland Clinic; Case Western Reserve UniversityRecruitingMultiple Myeloma in Relapse | Multiple Myeloma, RefractoryUnited States
-
Tel-Aviv Sourasky Medical CenterWeizmann Institute of ScienceRecruitingMultiple Myeloma in Relapse | Multiple Myeloma, RefractoryIsrael
-
Tel-Aviv Sourasky Medical CenterRecruitingRefractory Multiple Myeloma | Multiple Myeloma in RelapseIsrael
-
Zhejiang UniversityYake Biotechnology Ltd.RecruitingMultiple Myeloma in Relapse | Multiple Myeloma, RefractoryChina
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI)RecruitingPlasma Cell MyelomaUnited States
-
Fred Hutchinson Cancer CenterActive, not recruitingPlasma Cell Myeloma | Transplant-Related CarcinomaUnited States
-
TJ Biopharma Co., Ltd.Active, not recruitingRefractory Multiple Myeloma | Multiple Myeloma in RelapseChina, Taiwan
-
TJ Biopharma Co., Ltd.Active, not recruitingRefractory Multiple Myeloma | Multiple Myeloma in RelapseChina, Taiwan
-
Alliance Foundation Trials, LLC.Pharmacyclics LLC.Active, not recruitingMultiple Myeloma | Refractory Multiple Myeloma | Multiple Myeloma in RelapseUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedPlasma Cell Myeloma | Hematopoietic Cell Transplantation RecipientUnited States
-
National Cancer Institute (NCI)TerminatedStage II Multiple Myeloma | Stage III Multiple MyelomaUnited States
-
Ajai ChariCelgene CorporationCompletedMultiple Myeloma in Relapse | Multiple Myeloma, RefractoryUnited States
-
Zhejiang UniversityHangzhou Cheetah Cell Therapeutics Co., LtdRecruiting
-
920th Hospital of Joint Logistics Support Force...RecruitingMultiple Myeloma in Relapse | Multiple Myeloma, RefractoryChina
-
Roswell Park Cancer InstituteGlaxoSmithKlineRecruiting
-
SanofiRecruitingPlasma Cell Myeloma RefractoryFrance, Australia, Greece, Italy, Norway, United States, Portugal, Puerto Rico
-
Thomas Jefferson UniversityCompletedPlasma Cell MyelomaUnited States
-
University of NebraskaM.D. Anderson Cancer CenterTerminatedCabozantinib as a Targeted Strategy to Reverse Carfilzomib Resistance in Refractory Multiple MyelomaMultiple Myeloma | Refractory Multiple Myeloma | Relapsed/Refractory Multiple MyelomaUnited States
-
Oncopeptides ABTerminatedRelapsed Multiple Myeloma | Relapsed-Refractory Multiple MyelomaSerbia, Greece, Russian Federation, Czechia, Bulgaria, Georgia, Norway, Poland, Spain, Ukraine, Germany
-
Chongqing Precision Biotech Co., LtdEnrolling by invitationMultiple Myeloma in Relapse | Multiple Myeloma, RefractoryChina
-
Poitiers University HospitalSanofi; Celgene; Amgen; Intergroupe Francophone du MyelomeActive, not recruitingMultiple Myeloma in Relapse | Multiple Myeloma, RefractoryFrance
-
Gadeta B.V.Active, not recruitingMultiple Myeloma | Multiple Myeloma in Relapse | Multiple Myeloma, RefractoryUnited States
-
Cogent Biosciences, Inc.Seagen Inc.TerminatedMultiple Myeloma | Refractory Multiple Myeloma | Multiple Myeloma in RelapseUnited States